Melatonina Noxarem

Melatonin, the active ingredient in Melatonina Noxarem, is a melatonin receptor agonist presented as an oral formulation for oral use. It is used to help regulate the sleep‑wake cycle and is indicated for individuals experiencing insomnia, jet lag, or other sleep‑wake rhythm disturbances. Classified under the therapeutic class of sleep disorders, melatonin binds to MT1 and MT2 receptors in the brain to promote sleep onset.

GNH USA supplies Melatonina Noxarem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonina Noxarem is a melatonin receptor agonist used to address disorders of the sleep‑wake cycle. - Insomnia: helps reduce time to fall asleep and improve sleep continuity. - Jet lag: assists in adjusting circadian rhythm after rapid time‑zone travel. - Sleep‑wake rhythm disorders: supports normalization of abnormal sleep patterns.

Melatonina Noxarem may be associated with several adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness: feeling of sleepiness during daytime. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness or imbalance. - Gastrointestinal discomfort: nausea or stomach upset. - Vivid dreams: unusually intense or memorable dreams. - Fatigue: general lack of energy. - Excessive night‑time sleepiness: pronounced sleepiness after taking the dose.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression or increased anxiety. - Hormonal effects: alterations in menstrual cycle or reproductive hormones. - Cardiac arrhythmia: irregular heart rhythm (very rare). - Severe hypotension: marked drop in blood pressure (very rare).

When using Melatonina Noxarem, certain precautions should be observed to ensure safe and effective therapy. - Assess medical history: review sleep disorders, psychiatric conditions, and cardiovascular disease. - Use with caution in the elderly: increased sensitivity to sedative effects. - Avoid operating machinery: drowsiness may impair alertness. - Monitor for hormonal effects: especially in patients of reproductive age. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Melatonina Noxarem can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Immunosuppressants (e.g., cyclosporine): reduced drug levels. - Central nervous system depressants (e.g., benzodiazepines): excessive sedation.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in contraceptive effectiveness. - Antidiabetic agents: potential alteration of glucose control. - CYP1A2 inhibitors (e.g., fluvoxamine): increased melatonin concentrations.